Related Experiment Videos

Pharmacokinetics of intravenous chlorpheniramine in children

Insights

This study on chlorpheniramine disposition in children found that drug clearance generally decreased with age. The elimination half-life in children was shorter than in adults, likely due to higher clearance rates.

Area of Science:

  • Pharmacokinetics
  • Pediatric Pharmacology
  • Drug Metabolism

Background:

  • Chlorpheniramine is a commonly used antihistamine.
  • Understanding its pharmacokinetic profile in children is crucial for safe and effective dosing.

Purpose of the Study:

  • To characterize the disposition of chlorpheniramine in pediatric subjects.
  • To evaluate age-related changes in chlorpheniramine pharmacokinetics.

Main Methods:

  • Seven children aged 6-14 years received a 0.1 mg/kg intravenous dose of chlorpheniramine.
  • Serum chlorpheniramine levels were monitored over time.
  • Pharmacokinetic parameters including volume of distribution, clearance, and half-life were calculated.

Main Results:

  • Serum chlorpheniramine levels declined biexponentially.
  • Volume of distribution at steady state varied significantly (1.20–5.46 L/kg).
  • Chlorpheniramine clearance showed approximately twofold variation (234–470 mL/hr/kg) and decreased with age.
  • Mean elimination half-life in children was 9.6 hours, shorter than in adults.

Conclusions:

  • Pediatric chlorpheniramine pharmacokinetics exhibit significant intersubject variability, particularly in the distribution phase.
  • Age influences chlorpheniramine clearance, with higher rates observed in younger children.
  • The shorter elimination half-life in children is attributed to higher clearance compared to adults.

Related Concept Videos